Skip to main content
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

The Rockefeller University Institutional Biosafety Committee (IBC)

The Rockefeller University IBC provides oversight of research involving recombinant DNA conducted on campus and is specifically charged with ensuring compliance with the NIH Guidelines for Research Involving Recombinant DNA Molecules.

Work with recombinant DNA at The Rockefeller University must be conducted in accordance with the NIH Guidelines for Research Involving Recombinant DNA Molecules, regardless of the source of funding. These guidelines are designed to ensure that basic and clinical recombinant DNA research is conducted in accordance with responsible research practices, including provisions for safety of personnel and the environment.

The University IBC meetings are open to the public. The University reserves the right to hold executive sessions during IBC meetings. Executive sessions are not open to the public.  The next meeting of the RU IBC will be announced.  For information about upcoming meetings of the IBC, please contact the Chair of the IBC, c/o

For more information, please contact


Director, LS&EH
The Rockefeller University
1230 York Avenue, Box 51
New York, NY 10065